XAIR Form 4: Director reports loan-linked and amended warrant grants

Rhea-AI Filing Summary

Beyond Air, Inc. (XAIR) director reported warrant transactions on Form 4. In connection with a $2,000,000 loan to the company, the reporting person acquired warrants to purchase up to 512,821 shares at $1.95. Separately, an outstanding warrant for 494,332 shares at $7.586 was cancelled and a replacement warrant for 494,332 shares at $1.95 was issued. The warrants are exercisable on or after issuance and expire five years from their respective issuance dates.

Insights

Securities compliance analyst

Form 4 shows loan-linked and amended warrant activity.

The filing lists two warrant actions by a Beyond Air director. First, warrants for 512,821 shares at $1.95 were acquired in connection with a $2,000,000 loan to the issuer. Second, an existing warrant for 494,332 shares at $7.586 was cancelled and replaced with a warrant for 494,332 shares at $1.95.

The warrants are exercisable on or after issuance and generally expire five years after issuance, per the disclosure. An earlier warrant was originally issued on September 27, 2024, became exercisable on November 22, 2024, and will expire five years from that date.

These transactions affect potential share issuance depending on future exercises; actual impact will depend on exercise decisions under the stated terms.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Carey Robert

Role Director

Type	Security	Shares	Price	Value
Other	Warrants to purchase Common Stock	512,821	$0.00	--
Disposition	Warrants to purchase Common Stock	494,332	$0.00	--
Grant/Award	Warrants to purchase Common Stock	494,332	$0.00	--

Holdings After Transaction: Warrants to purchase Common Stock — 512,821 shares (Direct)

Footnotes (1)

1. In connection with a loan to the Issuer of $2,000,000, the Reporting Person acquired warrants to purchase up to 512,821 shares of Common Stock. The warrants will be exercisable on or after the issuance date and will expire five years following the date of issuance. The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant was originally issued on September 27, 2024, became exercisable on November 22, 2024, and will expire five years from November 22, 2024.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carey Robert

(Last) (First) (Middle)

C/O BEYOND AIR, INC.

900 STEWART AVENUE, SUITE 301

(Street)

GARDEN CITY NY 11530

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Beyond Air, Inc. [ XAIR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants to purchase Common Stock	$1.95	11/03/2025	11/03/2025	J(1)		512,821		(2)	(2)	Common Stock	512,821	(1)	512,821	D
Warrants to purchase Common Stock	$7.586	11/03/2025	11/03/2025	D(3)			494,332	(3)	(3)	Common Stock	494,332	(3)	0	D
Warrants to purchase Common Stock	$1.95	11/03/2025	11/03/2025	A(3)		494,332		(3)	(3)	Common Stock	494,332	(3)	494,332	D

Explanation of Responses:

1. In connection with a loan to the Issuer of $2,000,000, the Reporting Person acquired warrants to purchase up to 512,821 shares of Common Stock.

2. The warrants will be exercisable on or after the issuance date and will expire five years following the date of issuance.

3. The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant was originally issued on September 27, 2024, became exercisable on November 22, 2024, and will expire five years from November 22, 2024.

	/s/ Robert Carey	11/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Beyond Air (XAIR) disclose in this Form 4?

A director acquired warrants tied to a $2,000,000 loan (up to 512,821 shares at $1.95) and replaced an existing warrant (cancelling 494,332 at $7.586, issuing 494,332 at $1.95).

How many Beyond Air shares are covered by the new loan-linked warrants?

Warrants to purchase up to 512,821 shares at an exercise price of $1.95.

What happened to the prior 494,332-share warrant for Beyond Air (XAIR)?

It was cancelled at $7.586 and a replacement warrant for 494,332 shares at $1.95 was issued.

When can the reported warrants be exercised and when do they expire?

They are exercisable on or after issuance and expire five years from the respective issuance dates.

What dates were noted for the amended warrant history?

It was originally issued on September 27, 2024, became exercisable on November 22, 2024, and expires five years from November 22, 2024.

What is the relationship of the reporting person to Beyond Air (XAIR)?

The reporting person is a Director of Beyond Air, Inc.